RIPK-IN-4 is primarily used in research settings to study the role of receptor-interacting protein kinase (RIPK) pathways in cellular processes. It serves as a potent inhibitor of RIPK1, which is involved in regulating inflammation, cell survival, and programmed cell death (necroptosis). Researchers utilize RIPK-IN-4 to investigate its potential therapeutic effects in conditions where RIPK1 signaling is dysregulated, such as inflammatory diseases, neurodegenerative disorders, and certain types of cancer. By blocking RIPK1 activity, this compound helps in understanding the mechanisms of cell death and inflammation, paving the way for the development of targeted treatments for these diseases.